9 Eylül 2026, Çarşamba · 18:38 Piyasalar Kapalı
borsapanel.com Borsanın nabzı, tek panelde.
Abone Ol

Boston Scientific, siber saldırıdan sonra 2026 satışlarını ve kâr tahminini karşılama olasılığının düşük olduğunu söyledi

Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack

FILE PHOTO: A general view of the logo of Boston Scientific, a medical device developing and manufacturing company, in Galway, Ireland, April 11, 2025. REUTERS/Clodagh Kilcoyne/File Photo · Reuters
Reuters

Tue, September 8, 2026 at 2:30 PM GMT+3 1 min read

Sept 8 (Reuters) - Boston Scientific said on Tuesday it no longer expects to meet its previously issued third-quarter and full-year ‌2026 sales and adjusted profit forecasts, after a cybersecurity incident disrupted ‌the medical device maker's global operations.

An unauthorized activity on some of its information technology ​systems, first identified on August 25, caused a network outage that affected access to operating systems and business applications, disrupting manufacturing and the processing and shipment of customer orders, the company said in a regulatory filing. Its ‌shares were down 2.1% ⁠before the bell.

Boston Scientific had said in July it expects 2026 adjusted earnings of $3.28 to $3.32 per share, and ⁠forecast 2026 net sales growth between 5.5% and 6.5% on a reported basis.

For the third quarter, the company expected adjusted earnings to be in the ​range of ​80 cents to 82 cents per ​share.

The company said it has ‌made progress restoring affected systems, with major distribution centers now processing and shipping orders at or above normal levels. Sterilization facilities are operational and manufacturing has resumed across most of its facilities globally.

Boston Scientific said it expects to recover a portion of the lost revenue as it ‌ramps up operations, fulfills customer orders and ​reduces backlogs, but the full financial impact ​of the incident remains ​uncertain.

The incident is the latest in a series of ‌cyberattacks on the healthcare sector, with ​medical device makers Abbott ​Laboratories, Stryker and Medtronic, health insurer Clover Health and drugmaker Novo Nordisk among those recently hit.

Boston Scientific plans to provide an ​update on the operational ‌and financial impact of the incident when it reports third-quarter ​results on October 28.

(Reporting by Siddhi Mahatole in Bengaluru; Editing ​by Shilpi Majumdar and Leroy Leo)

Kaynak: Yahoo Finance
İlgili Haberler
Global How long should you wait between credit card applications? Yahoo Finance · 17 dk önce Global GameStop Rises 4% as Collectibles Sales Jump 57% and a Director Buys $1M Yahoo Finance · 24 dk önce Global Earnings call transcript: Moltiply Group posts mixed H1 2026 as q2 weakens Investing.com · 25 dk önce Global HCA Healthcare at wells fargo healthcare conference: growth offsets policy hit Investing.com · 25 dk önce Global Victrex Finds Its High-Performance Groove Again Yahoo Finance · 26 dk önce

Yorumlar (0)

Giriş yaparak yorum yazabilirsin.

İlk yorumu sen yaz.